Skip to main content

Table 4 Validation results in the German MARIE study

From: Coffee consumption modifies risk of estrogen-receptor negative breast cancer

Type of breast cancer

Daily coffee consumption

Controls/cases

ORa(95% CI)

ORb(95% CI)

All

≤ 1 cup

2,148/1,086

1.00 reference

1.00 reference

 

> 1 to 3 cups

2,136/1,050

0.97 (0.88 to 1.08)

0.97 (0.87 to 1.07)

 

> 3 to 5 cups

748/358

0.94 (0.82 to 1.09)

0.95 (0.82 to 1.10)

 

> 5 cups

363/157

0.85 (0.70 to 1.04)

0.87 (0.71 to 1.07)

 

P trend

 

0.128

0.173

ER-positive

≤ 1 cup

2,148/854

1.00 reference

1.00 reference

 

> 1 to 3 cups

2,136/822

0.96 (0.86 to 1.08)

0.95 (0.85 to 1.07)

 

> 3 to 5 cups

748/279

0.93 (0.79 to 1.09)

0.94 (0.80 to 1.10)

 

> 5 cups

363/129

0.90 (0.72 to 1.12)

0.92 (0.74 to 1.15)

 

P trend

 

0.221

0.302

ER-negative

≤ 1 cup

2,148/214

1.00 reference

1.00 reference

 

> 1 to 3 cups

2,136/212

1.00 (0.82 to 1.22)

1.02 (0.83 to 1.24)

 

> 3 to 5 cups

748/76

1.04 (0.79 to 1.36)

1.04 (0.78 to 1.37)

 

> 5 cups

363/25

0.67 (0.44 to 1.03)

0.67 (0.43 to 1.05)

 

P trend

 

0.288

0.326

PR-positive

≤ 1 cup

2,148/737

1.00 reference

1.00 reference

 

> 1 to 3 cups

2,136/686

0.93 (0.83 to 1.05)

0.92 (0.82 to 1.04)

 

> 3 to 5 cups

748/239

0.93 (0.78 to 1.10)

0.93 (0.78 to 1.10)

 

> 5 cups

363/115

0.93 (0.74 to 1.17)

0.96 (0.76 to 1.20)

 

P trend

 

0.299

0.363

PR-negative

≤ 1 cup

2,148/332

1.00 reference

1.00 reference

 

> 1 to 3 cups

2,136/348

1.06 (0.90 to 1.24)

1.06 (0.90 to 1.25)

 

> 3 to 5 cups

748/116

1.01 (0.80 to 1.26)

1.02 (0.81 to 1.28)

 

> 5 cups

363/39

0.68 (0.48 to 0.97)

0.70 (0.49 to 1.00)

 

P trend

 

0.194

0.280

  1. Multivariate-adjusted OR estimates and corresponding 95% CIs of postmenopausal breast cancer for coffee consumption in the German MARIE study, overall and stratified by breast cancer tumour subtype based on ER and PR status.
  2. aOdds ratio (OR) and corresponding 95% confidence intervals (CI) adjusted for matching factors age at enrolment in years (continuous) and study region.
  3. bOR and corresponding 95% CI adjusted for age at enrolment in years (continuous) and study region potential confounders (hormone replacement therapy (HRT, ever/never), ever smoked > 100 cigarettes, and education (low, medium, high) and average daily alcohol consumption (continuous, in g/day)).
  4. ER, estrogen receptor; PR, progesterone receptor.